Introduction
Corynebacterium glutamicum is a fast-growing, nonspore-forming, and nonpathogenic soil bacterium that belongs to actinomycetes. Since C. glutamicum was first identified as a natural glutamate producer, it has Abbreviations bsPadR, Bacillus subtilis PadR; cgVanR, Corynebacterium glutamicum VanR; CTD, C-terminal dimerization domain; EMSA, electrophoretic mobility shift assay; ITC, isothermal titration calorimetry; NTD, N-terminal DNA-binding domain; SAD, single-wavelength anomalous diffraction; SeMet, selenomethionine; wHTH, winged helix-turn-helix; WT, wild-type.
been used for the biotechnological production of various amino acids and vitamins. Moreover, because C. glutamicum degrades diverse aromatic compounds, C. glutamicum is a representative model system for understanding aromatic metabolism and can also be applied to remove aromatic pollutants in the environment [1, 2] .
Corynebacterium glutamicum features a catabolic pathway that uses aromatic lignocellulose-degradation products, such as ferulate, vanillin, vanillate, and protocatechuate, as carbon sources. Genomic sequence analysis of C. glutamicum identified a cluster of genes (vanA, vanB, vanK, and vanR) that is responsible for vanillate catabolism [3] [4] [5] . VanK is involved in vanillate transport, and VanA and VanB form a vanillatedegrading enzyme complex, vanillate-O-demethylase, that converts vanillate to protocatechuate [6] . VanR is a transcription factor that regulates the expression of the vanABK operon in response to vanillate [5, 7] . In the absence of vanillate, VanR represses the transcription of the vanABK genes by binding operator DNA that is located in the promoter region of the vanABK genes. On exposure to vanillate, VanR releases from the operator DNA, allowing RNA polymerase to initiate the transcription of the vanABK genes.
VanR is found only in actinomycetes and belongs to the PadR family, whose members contain a conserved DNA-binding winged helix-turn-helix (wHTH) domain that consists of a b-stranded wing and four a-helices [8] [9] [10] [11] [12] . The PadR family is further divided into two subfamilies (subfamily-1 and subfamily-2) based on the presence of an additional domain [13] . In PadR subfamily-1 members, the second domain is appended to the Cterminal end of the wHTH domain and is required for the formation of a functional dimer [10, 12] . In contrast, subfamily-2 members adopt a single domain structure that plays dual roles in DNA binding and dimerization [11] . Although subfamily-1 and subfamily-2 commonly contain the canonical PadR family-specific DNAbinding domain and are categorized into the same family, the additional C-terminal domain allows subfamily-1 members to assemble into a distinct quaternary structure and mediate functions that are different from those of subfamily-2 members [10] [11] [12] .
As bacterial PadR family members function as transcription factors that regulate gene expression generally in response to external chemicals, they harbor an effector-binding site to sense effector molecules and modulate their DNA-binding affinity depending on effector binding [7, [9] [10] [11] [12] [13] [14] [15] . For example, PadR, a subfamily-1 member, dynamically regulates the expression of a phenolic aciddegrading enzyme in response to toxic phenolic acids, such as p-coumarate and ferulate [8, 9, [16] [17] [18] [19] [20] [21] . PadR accommodates the phenolic acid in an interdomain pocket between two domains [12] . Effector binding induces structural changes in the effector-binding pocket and the subsequent rearrangement of the interdomain organization in PadR, resulting in the dissociation of PadR from DNA [12] . In contrast to the members of subfamily-1, subfamily-2 member LmrR has only one domain and presents an intersubunit pocket between two monomers to accommodate an effector molecule [11, 15] . PadR and LmrR, which represent subfamily-1 and subfamily-2, respectively, thus differ in effector-recognition modes and presumably in effector-mediated transcriptional regulation mechanisms. The effector-binding site of PadR is located in the interdomain pocket, whereas those of other two-domain transcription factors are generally confined to the C-terminal domain [12, 22, 23] . It should therefore be determined whether the effectorbinding mode of PadR is conserved in the PadR subfamily-1 or limited only to PadR.
VanR contains 192 residues, similar to PadR (182 residues), and is presumed to consist of two domains [7, 12] . As for PadR, VanR belongs to subfamily-1 and responds to a phenolic acid effector as a negative transcriptional regulator. However, the biological need that VanR meets is different from that of PadR. VanR transcriptionally regulates the catabolism of vanillate, a phenolic acid, to utilize vanillate as a carbon or energy source, whereas PadR is required to detoxify harmful phenolic acids, such as p-coumarate and ferulate [3] [4] [5] 7, 9] . Furthermore, the sizes of the effector molecules of VanR and PadR differ. Vanillate, which VanR specifically recognizes, is two carbon atoms shorter than the ferulate and p-coumarate effectors of PadR (Fig. 1) . Therefore, the effector-binding pockets of VanR and PadR would be different in size.
To reveal the common and distinct structural features of the effector-binding and DNA-binding modes of VanR, we determined the crystal structure of VanR in complex with vanillate. Vanillate was found in the interdomain cavity of VanR as p-coumarate has been for PadR. However, the effector-binding site of VanR is generated through a VanR-specific a-helix and is spatially distinct from that of PadR. Based on a comparative structural analysis and mutational study, we propose structural mechanisms used by VanR to interact with DNA and regulate DNA binding in response to vanillate.
Ni-NTA affinity chromatography and gel-filtration chromatography. The purified VanR protein could not be concentrated over 5 mgÁmL
À1
. To increase the protein concentration for crystallization, VanR was mixed with its effector, vanillate, and could then be concentrated up to~8 mgÁmL
. The crystal structure of VanR was determined by single-wavelength anomalous diffraction (SAD) phasing using selenomethionine (SeMet)-labeled protein (Table 1) . Using X-ray diffraction data from a native crystal, the final structure of VanR was calculated at 2.1 A resolution with an R free value of 22.4% (Table 2) .
The asymmetric unit of the VanR crystal contains two subunits (chains A and B) that assemble into a dimer as found in other PadR subfamily-1 proteins, such as PadR and AphA ( Fig. 2A-C) [10] . The dimer formation of VanR in the crystal is consistent with a previously reported gel-filtration chromatography analysis [7] . One VanR subunit consists of two domains, namely, an N-terminal DNA-binding domain (NTD; residues 1-86) and a C-terminal dimerization domain (CTD; residues 87-192) (Figs 2A,B and 3 ). The NTD of VanR contains four a-helices (a1, a2, a3, and a4) and two b-strands (b1 and b2) and adopts a typical winged helix-turn-helix (wHTH) motif as for other wHTH transcription factors, including MarR and GntR [22, 24] . The CTD is constituted by four ahelices (a5, a6, ai, and a7). As observed in other PadR subfamily-1 members, the a5, a6, and a7 helices of the VanR CTD directly mediate dimerization and contribute to the formation of the typical dolmen shape. The dimerization residues of VanR are largely conserved in VanR orthologs, presumably due to their functional significance ( Figs 2D and 3) . Strikingly, the VanR structure displays a VanR-specific a-helix (residues 143-150), ai, which is not found in the structures of other PadR subfamily-1 members (Fig. 2E ). In the primary sequence of VanR, the ai helix is flanked by the a6 and a7 helices in the CTD and belongs to the CTD (Figs 2A,B and 3 ). In the quaternary structure of VanR, the ai helix is located at the distal ends of a VanR dimer rod (Fig. 2B) . The ai helix protrudes from the a6 and a7 helices toward the NTD using the vertically positioned a6-ai and aia7 loops and mediates an NTD-CTD interdomain interaction within monomers (Fig. 2F) . Two proline residues (P143 and P153) are found at or near the ai helix and seem to facilitate the aberrant protrusion of the ai helix from the a6 and a7 helices. The ai helix exhibits amphipathicity, with apolar residues on one face of the helix and polar residues on the other face, presumably to stabilize NTD-CTD interactions (Fig. 2F) . Two apolar leucine residues (L145 and L149) are located on one face of the ai helix, and their side chains are inserted into the hydrophobic core generated by the a6 and a7 helices to bring the three ahelices together in the CTD. Moreover, the polar face of the ai helix mediates extensive hydrophilic 
b Numbers in parenthesis were calculated from data of the highest resolution shell.
interdomain interactions with residues from the a1 helix, the a1-a2 loop, and the a2 helix of the NTD. In addition to the NTD-CTD association, the unique ai helix of VanR is indispensable for effector recognition by VanR, as described below.
Effector-binding mode of VanR
To understand the first step of effector- . During structure refinement, nonproteinaceous electron density was observed in the cavity (Fig. 5B) . The shape and size of the electron density clearly indicated that the density corresponds to vanillate and allowed us to unambiguously orient vanillate in the cavity (Figs 2 and 5B). In the VanR-vanillate structure, vanillate is located inside a cavity that is surrounded by residues from the a2-a3 and a5 0 -a6 0 (the prime denotes the dimerization partner) loops and the a5 0 , a6, ai, and a7 helices (Fig. 5A,C ).
In the effector-binding site, the negatively charged carboxylic group of vanillate is stabilized by the positively charged guanidinium group of R148 from the ai helix and by the hydroxyl group of Y103 0 from the a5 0 -a6 0 loop through a salt bridge and hydrogen bonds (Fig. 5C ). The side chain of R148 is oriented toward the carboxylic group of vanillate through intramolecular hydrogen bonds with the A9 and S12 residues of VanR. At the opposite end of vanillate, two oxygen atoms from the methoxy and hydroxyl groups form hydrogen bonds with the hydroxyl group of VanR Y168, which is oriented for the intermolecular interaction through an intramolecular hydrogen bond to VanR S28. The three VanR residues, Y103, R148, and Y168, thus clutch the two polar ends of vanillate and seem to restrict the size and identity of VanR's effector molecules. To validate the specific interaction between VanR and vanillate observed in the structure, the R148 and Y168 residues of VanR were individually mutated to alanine residues (R148A and Y168A, respectively). The R148A and Y168A mutants lost the vanillate-binding capacity in ITC experiments but displayed similar DNA-binding patterns to the wild-type (WT) in an electrophoretic mobility shift assay (EMSA), suggesting that the side chains of R148 and Y168 are indispensable for vanillate recognition and have no effects on operator DNA binding (Fig. 4) .
In the effector-binding cavity of VanR, the middle part of vanillate interacts with S28, V29, A102 0 , L137, H142, T144, L145, and K164 via van der Waals and hydrophobic contacts (Fig. 5C) . Notably, the amine group of K164 forms multiple hydrogen bonds and salt bridges with VanR E105 0 and I160 residues and is oriented toward the a5-a6 loop, allowing the sidechain carbon atoms of K164 to stack on the benzene ring of vanillate through hydrophobic interactions.
Among the effector-binding residues of VanR, the T144, L145, and R148 residues are located at the 
b Numbers in parenthesis were calculated from data of the highest resolution shell. c R work = Σ||F obs | À |F calc ||/Σ|F obs |, where F calc and F obs are the calculated and observed structure factor amplitudes, respectively. d R free = as for R work , but for 5% of the total reflections selected at random and omitted from refinement. e Calculated using MolProbity (http://molprobity.biochem.duke.edu). (Fig. 4) .
In the sequence analysis, nine (S28, V29, A102, Y103, L137, L145, R148, K164, and Y168) of 12 vanillate-binding residues are highly conserved in VanR orthologs (Figs 3 and 5A,D) . In particular, residue 148 is an invariant arginine residue in all the VanR orthologs. Therefore, the effector-binding mode of C. glutamicum VanR (cgVanR) would be recapitulated in cgVanR orthologs.
Based on a cell-based assay, VanR was reported to respond to vanillate as a transcriptional regulator but not to ferulate [7] . Vanillate and ferulate are structurally similar, containing a 4-hydroxy-3-methoxy-phenyl group and a carboxylic group (Fig. 1) . However, the linear length of vanillate is~2. 3 A shorter than ferulate because vanillate lacks the two internal carbon atoms of ferulate. To determine why VanR does not respond to ferulate, the direct interaction between VanR and ferulate was analyzed by ITC. VanR displayed no ferulate-binding signals in the ITC experiment, suggesting that VanR does not respond to ferulate due to the lack of the ferulate-binding affinity of VanR (Fig. 4A) . It is interesting that VanR distinguishes ferulate from vanillate by a two-carbon difference. The structural analysis of the VanR-vanillate complex indicates that VanR prefers vanillate to ferulate using the selectivity gauge of the ai helix. In the VanR cavity, the R148 residue from the ai helix directly interacts with the carboxylic group of vanillate, perfectly accommodating the size of vanillate (Fig. 6A) . When the longer molecule, ferulate, is placed in the cavity, the ferulate molecule extends from the cavity and sterically clashes with R148, which does not move due to its stable interactions with VanR A9 and S12 (Fig. 6B) .
Comparison of effector-binding modes of VanR and PadR
VanR binds its effector using the interdomain cavity that is generated between the NTD and the CTD, as observed for PadR (Fig. 7A) [12] . Moreover, VanR and PadR dimers each simultaneously bind two effector molecules. Despite their common features, VanR differs from PadR in effector-binding mode due to the VanR-specific ai helix (Fig. 7) . In the VanR structure, the ai helix is positioned at the distal end of the VanR dimer and contributes to the creation of a unique effector-binding cavity, allowing effector binding to occur nearer to the distal end compared to that found in PadR (Fig. 7A) . The ai helix and its neighboring a6-ai loop are involved in completely enclosing the vanillate effector molecule by covering the carboxylic end and the benzene ring of vanillate (Fig. 7B) . In contrast, the cavity of PadR is partially open to solvent. Furthermore, the vanillate molecule in the VanR-vanillate structure is arranged in an opposite orientation to the p-coumarate or ferulate molecules of PadR because the arginine residues of VanR and PadR (R148 at VanR ai and R164 at PadR a7) that interact with the carboxylic group of effectors are located on the opposite sides of the effector-binding cavities (Fig. 7B) . Considering these observations, we conclude that VanR displays a unique effector-recognition mode that is distinguished from that of PadR in the location and accessibility of its effector-binding site as well as the orientation of the effector.
DNA-binding mode of VanR
VanR binds DNA at the promoter region of the vanABK genes for transcriptional repression [7] . Indeed, in our EMSA, VanR interacted with 50-bp dsDNA containing the operator sites of VanR (Fig. 4B) . To predict the DNA-binding site of VanR, we performed an electrostatic potential analysis on the molecular surface of the VanR structure. A positively charged elongated patch was identified at the b1-b2 loop, b2 strand, a3 helix, and a4-a5 loop (Fig. 8A) . The VanR residues in the positive patch are expected to accommodate the negatively charged phosphate groups of DNA and are highly conserved among VanR orthologs (Fig. 8B) . Furthermore, a comparative analysis of the VanR and PadR-DNA structures suggests that VanR binds the operator DNA in a similar mode to PadR (Fig. 9) [12] . In the PadR-DNA structure, the PadR-DNA-binding interface can be separated into major and minor groove interaction sites and their boundary interaction site (Fig. 9A) . The major groove interaction is mediated by 14 residues of PadR. Among them, 10 residues adopt conformations similar to those of their corresponding VanR residues, and these 10 pairs also have identical sequences, collectively suggesting that the major groove interaction of VanR occurs in a similar manner to that of PadR (Fig. 9B) . In particular, two tyrosine residues (PadR Y20 and Y42; VanR Y19 and Y41) that were shown to form a hot spot in the major groove interaction of PadR are highly conserved in VanR orthologs, with 95% and 100% sequence identities, respectively (Fig. 9C) [12] . To verify the importance of the two tyrosine residues in operator DNA recognition, we individually mutated the Y19 and Y41 residues of VanR to alanine residues and monitored the VanR-DNA interaction. In the EMSA, the Y19A and Y41A mutants did not bind the operator DNA unlike the WT, suggesting that Y19 and Y41 are required for DNA recognition (Fig. 9D) . In addition to the two tyrosine residues, PadR S39 was shown to contribute to the major groove interaction of PadR [12] . The VanR residue, S38, that corresponds to PadR S39 is positioned at the tentative major groove interaction site, and its alanine mutant exhibited lower DNA binding than the WT.
In contrast to the major groove interaction site, only two of eight residues that interact with the minor groove of dsDNA or the boundary between the major and minor grooves are conserved in structural positions and sequences between PadR (G62 and K67) and VanR (G61 and K67) (Fig. 9E) [12] . Moreover, cgVanR residues at the tentative minor groove and boundary interaction sites exhibit lower sequence conservation across VanR orthologs than those of the tentative major groove interaction site (Fig. 9F) . To be consistent, the minor groove interaction in the PadR-DNA structure is primarily mediated by the main chain atoms of PadR [12] . However, PadR L65 and K67 employ their side chains for DNA binding. The side chain of PadR L65 is inserted into the minor groove, and the side chain of PadR K67 participates in multiple interactions with the backbone atoms of DNA. When the PadR and VanR structures are overlaid, PadR L65 and K67 are positionally equivalent to VanR W60 and K67, respectively. The important functions of VanR W60 and K67 in DNA binding were confirmed by the mutational study. The W60A and K67D mutants of VanR were deficient in DNA The VanR dimer is represented by surfaces that range from green to white based on sequence conservation (high conservation, green; low conservation, white). The dsDNA structure (black) was obtained from the PadR-DNA structure (PDB ID 5X11) whose NTD had been superimposed on the NTD of VanR. 
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Effector-mediated regulatory mechanism of VanR
Vanillate relieves the VanR-mediated inhibition of VanABK expression [3, 7] . In our EMSA, VanR-DNA binding was inhibited by vanillate (Fig. 10A) . Due to the unavailability of a DNA-bound VanR structure, the vanillate-induced derepression mechanism is not currently understood at a molecular level. However, our comparative analysis of the VanR and PadR structures combined with a mutational study allows us to propose a transcriptional derepression mechanism used by VanR. In PadR, effector binding to the interdomain pocket induces NTD-CTD interdomain reorganization through the allosteric center of Q32 and F33 located at the a2-a3 loop [12] . Vanillate binding to VanR may analogously cause conformational changes in the VanR structure to disfavor DNA binding. In the VanR-vanillate structure, V29 adopts a squat position to bind the vanillate effector (Fig. 5C) ; otherwise, VanR V29 would sterically clash with vanillate, suggesting that V29 changes its conformation in response to vanillate as a DNA-binding regulatory mechanism. To validate the regulatory role of the V29 residue, we mutated V29 to an alanine residue. The V29A mutant of VanR exhibited a similar vanillate-binding affinity (K d , 20 AE 2 lM) to the VanR WT (K d , 13 AE 1 lM) (Fig. 10B) . However, the inhibitory effect of vanillate on the VanR-DNA interaction was mitigated by the V29A mutation, indicating the regulatory function of VanR V29 in effector-mediated transcriptional regulation (Fig. 10A) . Moreover, the V29 residue is highly conserved in VanR orthologs with sequence identities of 97% (Fig. 5A,D) . Therefore, we propose that V29 at the a2-a3 loop functions as an allosteric center that shifts the NTD upon vanillate binding, similar to the Q32 and F33 residues of PadR (Fig. 10C) [12] . When VanR is bound to DNA, the a2-a3 loop containing V29 is closer to the CTD than in the vanillate-binding form to fill the unoccupied vanillate-binding cavity. When vanillate binds VanR, vanillate pushes the a2-a3 loop and its connected DNAbinding helices, a2 and a3, resulting in the interdomain reorganization of VanR into a DNA-binding incompatible form.
In conclusion, our structural, mutational, and biophysical studies clearly demonstrated that VanR employs a unique ai helix to accommodate the vanillate effector. Additionally, we proposed the DNAbinding mode and the vanillate-induced derepression mechanism of VanR. However, structural study of the DNA-bound form of VanR is required to confirm these proposed features.
Materials and methods

Construction of the VanR expression vector
The VanR gene was PCR-amplified from the genomic DNA of C. glutamicum using primers containing BglII or SalI restriction enzyme sites. The PCR product that corresponds to the VanR gene was digested by BglII and SalI restriction enzymes and inserted using T4 DNA ligase into a modified pET49b plasmid that had been digested by BamHI and SalI restriction enzymes [25, 26] . The modified pET49b plasmid allows VanR to be expressed in fusion with an N-terminal His 6 -tag and a thrombin cleavage site. Point mutations were made in the VanR gene using the QuikChange site-directed mutagenesis protocol. The nucleotide sequence of the VanR expression vector was confirmed by DNA sequencing, and the vector was transformed into E. coli BL21 (DE3) and B834 (DE3) cells for 
Crystallization and data collection
Protein crystallization was performed using the sitting-drop vapor-diffusion method at 18°C. For crystallization, the VanR protein was concentrated using centrifugal filters. The VanR protein alone could not be concentrated over 5 mgÁmL À1 . To obtain a more concentrated protein sample,
VanR protein was mixed with vanillate and then concentrated to 8 mgÁmL
À1
. The native VanR protein in complex with vanillate in 20 mM Tris, pH 8.0, and 150 mM NaCl was crystallized in 0.2 M calcium acetate, 14% PEG 8000, and 0.1 M sodium cacodylate, pH 6.5. Needle-shaped crystals were obtained and soaked in 10 mM vanillate before X-ray diffraction data collection to enhance the occupancy of vanillate in the crystal structure. SeMet VanR-vanillate crystals were produced in 0.2 M calcium acetate, 0.1 M Hepes, pH 7.4, 14% PEG 8000, and 1% PEG 3350. The native and SeMet crystals were cryoprotected using 25% glycerol. X-ray diffraction data were collected at beamlines 5C and 7A of the Pohang Accelerator Laboratory. Data processing and scaling were carried out using the HKL2000 software (HKL Research, Charlottesville, VA, USA).
Structure determination, refinement, and analysis
The phases of the VanR-vanillate structure were determined by SAD phasing using X-ray diffraction data collected at the peak wavelength for a SeMet crystal. The initial model of SeMet VanR was built using the COOT program and was used to search for two VanR chains with Xray diffraction data obtained from a native crystal [27] . The final model of the VanR-vanillate complex was produced by iterative model building and refinement cycles using the COOT and REFMAC5 programs, respectively [27, 28] . The electrostatic potentials of VanR were calculated by applying the AMBER force field using the PDB2PQR program (pH 7.0) and subsequently by solving the linearized Poisson-Boltzmann equation using the APBS program (univalent ion concentration, 0.15 M; temperature, 310 K) [29, 30] . Structure figures were prepared using the PYMOL program (https://pymol.org).
ITC
A thermodynamic analysis of the interaction between VanR (WT, V29A, R148A, Y168A, and Dai) and effector molecules (vanillate and ferulate) was performed by ITC using a MicroCal iTC200 instrument (Malvern) at 25°C. To prepare samples in identical buffer for ITC experiments, VanR protein was dialyzed against ITC assay buffer (20 mM Tris, pH 8.0, and 150 mM NaCl), and effector was dissolved in the ITC buffer. Effector at a concentration of 1.3 mM in a syringe was titrated into a sample cell containing 80 lM VanR protein with a first injection of 0.4 lL and then 18 successive injections of 2 lL each. The ITC data were evaluated with the ORIGIN 7 software (MicroCal, Northampton, MA, USA) using the one-site binding model [31] .
EMSA
We performed the EMSA to analyze VanR-DNA binding and vanillate-mediated inhibition of the VanR-DNA interaction. For the VanR-DNA-binding experiments, 25 nM fluorescein-labeled dsDNA containing the operator sites of VanR was incubated with the VanR protein in various molar ratios. To monitor vanillate-mediated inhibition of the VanR-DNA interaction, VanR dimerdsDNA mixture at the 4 : 1 molar ratio was incubated with vanillate at various concentrations (2-18 mM). The mixtures were electrophoresed using a polyacrylamide gel in TBE buffer. DNA bands in the electrophoretic gel were visualized by the ImageQuant LAS 500 instrument (GE Healthcare Life Sciences, Pittsburgh, PA, USA).
